VERIFIEDET Markets·4 Sept 2026neutral

Block deal alert! Gland Pharma shares fall 3% as 1.2 crore shares change hands in 2 block deals; promoter Fosun likely seller

AI Summary

·Gland Pharma shares declined by 3% following a block deal where 1.2 crore shares were traded.
·The company's VSEZ facility concluded a USFDA inspection with zero observations.
·Gland Pharma announced strong Q1FY27 results, reporting increased profit and revenue with substantial growth in its CDMO and B2B segments.